Skip to main content
David Ettinger, MD, Oncology, Lutherville, MD

DavidSeymourEttingerMD

Oncology • Lutherville, MD

Professor of Oncology, Professor of Gynecology and Obstetrics, Professor of Medicine, Professor of Otolaryngology-Head and Neck Surgery, Professor of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine

Join to view full profile

Dr. Ettinger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ettinger's full profile

Already have an account?

  • Office

    10755 Falls Rd
    Lutherville, MD 21093
    Phone+1 410-583-2970

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1973 - 1975
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1968 - 1971
  • Albany Medical Center
    Albany Medical CenterInternship, Transitional Year, 1967 - 1968
  • University of Louisville School of Medicine
    University of Louisville School of MedicineClass of 1967

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1974 - 2024
  • DC State Medical License
    DC State Medical License 2013 - 2020
  • MN State Medical License
    MN State Medical License 1968 - 1987
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • PD-L1 Inhibitor Avelumab May Improve Survival in Metastatic Urothelial Carcinoma
    PD-L1 Inhibitor Avelumab May Improve Survival in Metastatic Urothelial CarcinomaOctober 7th, 2015
  • Dr David Ettinger Discusses the Road Ahead for Immunotherapy in NSCLC
    Dr David Ettinger Discusses the Road Ahead for Immunotherapy in NSCLCOctober 6th, 2015

Grant Support

  • Eastern Cooperative Oncology GroupNational Cancer Institute1985–1992

Professional Memberships

External Links

Dr. David Ettinger, Dr. David Ettinger, MD, Dr. D Ettinger, Dr. David Seymour Ettinger